Faculty profile
Benjamin Rogers
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,908,674
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
CIHR · 2025 · Principal investigator
- $309,825
BALANCE+ PRO (Patient-informed Relevant Outcomes)
CIHR · 2024 · Co-investigator
- $729,947
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
CIHR · 2022 · Principal investigator
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Ong, Sean W; Pinto, Ruxandra; Rogers, Benjamin A
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Duration; Antibiotic Oral Switch; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Clinical Trial
BALANCE+ PRO (Patient-informed Relevant Outcomes)
Principal investigators: Somayaji, Ranjani; Fiest, Kirsten M; Fowler, Robert A
Keywords: Balance+ Trial; Blood Stream Infections; Critical Illness; Health Outcomes; International Study; Mixed-Methods Study; Patient Informed Outcomes; Patients And Family Members; Quality Of Life; Severe Infections
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.